Immunotherapy Part 3: Common Controversies and Remaining Questions

from SGO on the GO · host The Society of Gynecologic Oncology

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology - VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

Episode metadata supplied by the publisher feed · Published Mar 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Immunotherapy Part 3: Common Controversies and Remaining Questions

0:00 17:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of SGO on the GO?

This episode is 17 minutes long.

When was this SGO on the GO episode published?

This episode was published on March 11, 2024.

Can I download this SGO on the GO episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!